Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Samuel Heath & Sons plc (HSM.L)
Birmingham, GB
Established in Birmingham, UK, in 1820, Samuel Heath & Sons plc operates as a prominent manufacturer and marketer of a comprehensive array of products specifically designed for both the builders' hardware and bathroom sectors. The company's extensive offerings encompass a variety of taps and faucets for basins, baths, bidets, and kitchens, alongside diverse showering systems, including both concealed and exposed options, complete with their associated accessories and ancillaries. Their portfolio also features a broad selection of general bathroom accessories, toilet fittings, and bath ancillaries. Beyond bathroom installations, Samuel Heath provides essential hardware for external and internal doors, windows, and other general fittings such as cupboards and cabinets. Although its primary market is the United Kingdom, the company actively engages in international exports of its goods.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -4.41% | +0.00% | -2.99% | -4.41% | -4.41% | +4.84% | -23.53% | -7.14% | +17.12% | +15.25% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Construction: +2.5%-3.1% Q3'25: -1.1% (vs Q4'23)
-
EPS growth Construction: +11.1%+16.7% ★ Q3'25: +31.3% (vs Q4'23)
-
FCF margin FCF growth · Construction: +30.9%+6.7% ★ Q3'25: +12.0% (vs Q4'23)
-
EBIT margin Construction: +8.5%+7.9% Q3'25: +7.0% (vs Q4'23)
-
ROIC Construction: +6.4%+8.6% ★ Q3'25: +21.5% (vs Q4'23)
-
Share dilution Construction: +0.4%+0.0% Q3'25: +0.0% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Construction: 0.05×0.10× ★ Q3'25: 0.04× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-27 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-26 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-22 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-21 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-20 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-19 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-18 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-15 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-14 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-13 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-12 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-11 | A+ | 5/5 | 4/5 | 3/5 | 5/5 | 4/5 | 4/5 | 5/5 |
| 2026-05-08 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-07 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-06 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-05 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-05-01 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-30 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-29 | A+ | 4/5 | 4/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-27 | A | 4/5 | 3/5 | 3/5 | 5/5 | 3/5 | 4/5 | 5/5 |
| 2026-04-24 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-23 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-22 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-21 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-17 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
| 2026-04-16 | A | 4/5 | 3/5 | 3/5 | 5/5 | 2/5 | 4/5 | 5/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Martyn Peter Whieldon | MD & Executive Director | 356.0K | male |
| Simon George Pinckney Latham FCCA | Secretary & Executive Director | 175.0K | male |
| Martin J. Harrison | Manufacturing Director & Director | 171.0K | male |
| Adam Daniels | Development Director & Member of Group Management Board | — | male |
| Rolando Guselli | Member of Group Management Board | — | — |
| Sarn Lloyd | Head of Finance & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for HSM.L
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
